Arcus Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Arcus Biosciences, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2020 to Q4 2024.
  • Arcus Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2024 was $133M, a 10.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Arcus Biosciences, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $133M -$16M -10.7% Dec 31, 2024 10-K 2025-02-25
Q4 2023 $149M -$10M -6.29% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $159M +$502K +0.32% Dec 31, 2022 10-K 2023-02-28
Q4 2021 $158M +$136M +612% Dec 31, 2021 10-K 2022-02-23
Q3 2021 $67.7M Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $68.8M Jun 30, 2021 10-Q 2021-08-05
Q4 2020 $22.3M Dec 31, 2020 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.